- Home
- EDSA vs WKSP Comparison
EDSA vs WKSP Comparison
Compare EDSA & WKSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- WKSP
- Stock Information
- Founded
- EDSA 2015
- WKSP 2003
- Country
- EDSA Canada
- WKSP United States
- Employees
- EDSA N/A
- WKSP N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- WKSP Auto Parts:O.E.M.
- Sector
- EDSA Health Care
- WKSP Consumer Discretionary
- Exchange
- EDSA Nasdaq
- WKSP Nasdaq
- Market Cap
- EDSA 13.7M
- WKSP 12.5M
- IPO Year
- EDSA N/A
- WKSP N/A
- Fundamental
- Price
- EDSA $4.32
- WKSP $0.48
- Analyst Decision
- EDSA Strong Buy
- WKSP
- Analyst Count
- EDSA 2
- WKSP 0
- Target Price
- EDSA $39.00
- WKSP N/A
- AVG Volume (30 Days)
- EDSA 8.4K
- WKSP 416.9K
- Earning Date
- EDSA 08-09-2024
- WKSP 11-12-2024
- Dividend Yield
- EDSA N/A
- WKSP N/A
- EPS Growth
- EDSA N/A
- WKSP N/A
- EPS
- EDSA N/A
- WKSP N/A
- Revenue
- EDSA N/A
- WKSP $3,732,032.00
- Revenue This Year
- EDSA N/A
- WKSP $386.78
- Revenue Next Year
- EDSA N/A
- WKSP $294.52
- P/E Ratio
- EDSA N/A
- WKSP N/A
- Revenue Growth
- EDSA N/A
- WKSP 1190.52
- 52 Week Low
- EDSA $2.46
- WKSP $0.36
- 52 Week High
- EDSA $8.33
- WKSP $2.04
- Technical
- Relative Strength Index (RSI)
- EDSA 53.46
- WKSP 46.72
- Support Level
- EDSA $4.22
- WKSP $0.39
- Resistance Level
- EDSA $5.00
- WKSP $0.45
- Average True Range (ATR)
- EDSA 0.25
- WKSP 0.04
- MACD
- EDSA 0.04
- WKSP 0.01
- Stochastic Oscillator
- EDSA 53.06
- WKSP 67.56
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers.